Kevin Ballinger, Aldevron CEO (via Boston Scientific)
With its campus expanding as gene therapy booms, Aldevron brings in a top exec from a medtech giant to steer the course
We now know where Kevin Ballinger was headed when he unexpectedly handed in his resignation earlier this month as one of the top EVPs at …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
